Veracity Logic Appoints Mark M. Paul as Head of Sales and Marketing

Share Article

Veracity Logic, a provider of interactive web and voice technology solutions for clinical trial management, announced the addition of Mark M. Paul, MBA, formerly CEO of StatWorks and a veteran of the clinical trials industry, as Managing Partner, Business Development, and head of the company’s sales and marketing areas.

Veracity Logic, a provider of interactive web and voice technology solutions for clinical trial management, announced the addition of Mark M. Paul, MBA, formerly CEO of StatWorks and a veteran of the clinical trials industry, as Managing Partner, Business Development, and head of the company’s sales and marketing areas.

“We are pleased to add Mark to our team to strengthen our position as a growing interactive response technology (IRT) provider,” said David Goldston, Managing Director of Veracity Logic (VL). “Mark’s long history in clinical trials and technology development will significantly expand our ability to reach new customers across multiple channels where our VLIRT™ platform (web and voice interactive systems) can significantly increase the effectiveness of a study through real time subject and inventory management.”

“Veracity Logic’s product line is strong and very cost effective,” added Mr. Paul, “Our long history of providing interactive web and voice solutions for clinical studies across numerous countries and languages makes us a very suitable partner for study sponsors, clinical supply groups, and technology companies in utilizing real time information on site performance, subject status, and drug supply inventory to better manage their clinical trials. Our growth potential is significant and I’m excited to be on board as a manager and investor.”

About Mark M. Paul
Mr. Paul has served in the clinical trials industry for over 20 years. At Veracity Logic, he serves as head of business development, sales and marketing. Mr. Paul began his drug development career at Quintiles and served in information technology, project management, human resources, and business development. Mr. Paul was Project Director for several global programs and NDA submissions. Mr. Paul has led several innovative technology development teams including the design and rollout of a global data integration and dashboard solution. Mr. Paul has served as Director, eClinical Technologies for Quintiles, CEO of StatWorks, co-founder and CEO of PharPoint Research, and Vice President, Business Development at Pharm-Olam International. Mr. Paul received his B.A. in Economics from the College of William and Mary and his M.B.A. from the Kenan-Flagler School of Business at UNC-Chapel Hill.

About Veracity Logic
Veracity Logic is a provider of software systems for clinical study management including interactive web and voice response technology used to manage subject activities like randomizations (static, dynamic and adaptive), inventory activities like predictive re-supply and expiry management, and subject diaries or electronic patient reported outcomes (ePRO). Since 2006, Veracity Logic has participated in over 60 studies involving over 2,000 sites, 15,000 subjects, and 5,000 users. Veracity Logic’s solutions have been used in over 30 countries and 25 languages. Veracity Logic’s VLIRT platform is fully redundant, validated, and supported on a 24x7 basis worldwide. Additional information on Veracity Logic is available at http://www.veracitylogic.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mark Paul

+1 (919) 904-4070
Email >
Visit website